Total patients, n | 50 |
Median age, years (range) | 56 (21–80) |
Sex (Females: Males) | 22:28 |
Diagnosis, n (%) | |
 Hodgkin lymphoma (HL) | 14 (28%) |
 Follicular lymphoma (FL) | 13 (26%) |
 Diffuse large B-cell lymphoma (DLBCL) | 7 (14%) |
 Mantle Cell lymphoma (MCL) | 4 (8%) |
 Low-grade B-cell lymphoma unclassifiable | 4 (8%) |
 Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) | 2 (4%) |
 Burkitt lymphoma | 1 (2%) |
 Post-transplant lymphoproliferative disorder (PTLD) | 2 (4%) |
 Othersa | 3 (6%) |
Ann Arbor Stage | |
 Stage I | 11 (22%) |
 Stage II | 6 (12%) |
 Stage III | 8 (16%) |
 Stage IV | 24 (48%) |
 Otherb | 1 (2%) |